Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 110 citing Ranson: Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation.... (0.12 sec) 

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

- nih.gov - Free from Publisher
JB Jonas, I Kreissig, P Hugger, G Sauder, S … - British Journal of Ophthalmology, 2003 - bjo.bmj.com
Results: Visual acuity increased significantly (p <0.001) from 0.16 (0.11) to a
mean maximum of 0.23 (0.17). Postoperative visual acuity was highest 1–3
months after the injection. 47 (66.2%) eyes gained in maximal visual acuity ...
Cited by 530 - Related articles - BL Direct - All 11 versions

Intraocular pressure after intravitreal injection of triamcinolone acetonide

- nih.gov - Free from Publisher
JB Jonas, I Kreissig, R Degenring - British Journal of Ophthalmology, 2003 - bjo.bmj.com
Results: IOP increased significantly (p<0.001) from 15.43 (3.26) mm Hg
preoperatively to a mean maximum of 23.38 (8.37) mm Hg (range 13–64 mm Hg)
postoperatively. An IOP rise to values higher than 21 mm Hg was observed in ...
Cited by 321 - Related articles - BL Direct - All 9 versions

Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies


J Ambati, BK Ambati, SH Yoo, S Ianchulev, … - Survey of ophthalmology, 2003 - Elsevier
Age-related macular degeneration is the principal cause of registered legal
blindness among those aged over 65 in the United States, western Europe,
Australia, and Japan. Despite intensive research, the precise etiology of ...
Cited by 319 - Related articles - All 10 versions

Current concepts in the pathogenesis of age-related macular degeneration

- retina.it [PDF] 
MA Zarbin - Archives of ophthalmology, 2004 - archopht.highwire.org
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 300 - Related articles - BL Direct - All 9 versions

Noninfectious endophthalmitis associated with intravitreal triamcinolone injection


DB Roth, J Chieh, MJ Spirn, SN Green, DL … - Archives of Ophthalmology, 2003 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 194 - Related articles - BL Direct - All 5 versions

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration


JB Jonas, I Akkoyun, WM Budde, I Kreissig, … - Archives of Ophthalmology, 2004 - archopht.highwire.org
Methods This prospective, comparative nonrandomized clinical interventional
study included 13 patients with progressive exudative age-related macular
degeneration with occult, or predominantly occult, subfoveal ...
Cited by 136 - Related articles - BL Direct - All 4 versions

Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal …

- nih.gov - Free from Publisher
E Rechtman, RP Danis, LM Pratt, A Harris - British Journal of Ophthalmology, 2004 - bjo.bmj.com
Results: Fourteen patients were evaluated. Eleven received one initial combined
treatment and three received an additional combined treatment after 6 months.
Median follow up was 18 months (range 12 to 25 months). Overall, 7% gained ...
Cited by 128 - Related articles - BL Direct - All 9 versions

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal …


AJ Augustin, U Schmidt-Erfurth - Ophthalmology, 2006 - Elsevier
Cited by 111 - Related articles - All 10 versions

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and …


JB Jonas - Acta Ophthalmologica Scandinavica, 2005 - duanesolution.com
Cited by 89 - Related articles - Cached - BL Direct - All 5 versions

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult …


AJ Augustin, U Schmidt-Erfurth - American journal of ophthalmology, 2006 - Elsevier
The mean number of treatments needed was 1.8. Thirty-four eyes (82.9%) required
one retreatment at three months. No additional retreatments were necessary.
Visual acuity improved gradually in most of the patients with mean values ...
Cited by 79 - Related articles - All 20 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google